These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3467156)

  • 1. Differentiation of Mycobacterium gordonae from Mycobacterium scrofulaceum and Mycobacterium szulgai by susceptibility to enoxacin (antimycobacterial activity of enoxacin).
    Tsukamura M
    Microbiol Immunol; 1986; 30(9):931-3. PubMed ID: 3467156
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of five fluoroquinolones against Mycobacterium avium-intracellulare complex and M. xenopi.
    Rastogi N; Goh KS; David HL
    Ann Inst Pasteur Microbiol; 1988; 139(2):233-7. PubMed ID: 3165641
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative in-vitro activity of five fluoroquinolones against mycobacteria.
    Davies S; Sparham PD; Spencer RC
    J Antimicrob Chemother; 1987 May; 19(5):605-9. PubMed ID: 3112094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of Mycobacterium chelonei from M. fortuitum by ciprofloxacin susceptibility.
    Collins CH; Yates MD; Uttley AH
    J Hyg (Lond); 1985 Dec; 95(3):619-21. PubMed ID: 2936800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antimycobacterial activity of a new antibacterial substance DL-8280--differentiation between some species of mycobacteria and related organisms by the DL-8280 susceptibility test.
    Tsukamura M
    Microbiol Immunol; 1983; 27(12):1129-32. PubMed ID: 6587177
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro activity of linezolid against slowly growing nontuberculous Mycobacteria.
    Brown-Elliott BA; Crist CJ; Mann LB; Wilson RW; Wallace RJ
    Antimicrob Agents Chemother; 2003 May; 47(5):1736-8. PubMed ID: 12709349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro susceptibility of Mycobacterium marinum to dihydromycoplanecin A and ten other antimicrobial agents.
    Arai H; Nakajima H; Kaminaga Y
    J Dermatol; 1990 Jun; 17(6):370-4. PubMed ID: 2384640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for determining the antimicrobial susceptibility of mycobacteria.
    Alcaide F; Esteban J; González-Martin J; Palacios JJ
    Enferm Infecc Microbiol Clin; 2017 Oct; 35(8):529-535. PubMed ID: 27236235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity and distribution of alpha antigens of Mycobacterium avium-intracellulare, Mycobacterium scrofulaceum, and related species of mycobacteria.
    Tasaka H; Nomura T; Matsuo Y
    Am Rev Respir Dis; 1985 Jul; 132(1):173-4. PubMed ID: 2409853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of six fluorinated quinolones against Mycobacterium tuberculosis.
    Berlin OG; Young LS; Bruckner DA
    J Antimicrob Chemother; 1987 May; 19(5):611-5. PubMed ID: 3112095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole.
    Casal MJ; Rodriguez FC; Benavente MC
    Antimicrob Agents Chemother; 1985 Feb; 27(2):282-3. PubMed ID: 3857020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity of the new macrolide A-56268 against mycobacteria.
    Berlin OG; Young LS; Floyd-Reising SA; Bruckner DA
    Eur J Clin Microbiol; 1987 Aug; 6(4):486-7. PubMed ID: 2959472
    [No Abstract]   [Full Text] [Related]  

  • 13. Susceptibilities of Mycobacterium fortuitum biovariant fortuitum and the unnamed third biovariant complex to heavy-metal salts.
    Wallace RJ; Steele LC; Forrester GD; Swenson JM; Hull SI
    Antimicrob Agents Chemother; 1984 Oct; 26(4):594-6. PubMed ID: 6517549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of antibiotic resistance in Mycobacterium intracellulare.
    Mizuguchi Y; Udou T; Yamada T
    Microbiol Immunol; 1983; 27(5):425-31. PubMed ID: 6312275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial activity of enoxacin: comparison with aminoglycosides, beta-lactams and other antimicrobial agents.
    Vanhoof R; Hubrechts JM; Roebben E; Claeys M; Nyssen HJ
    J Antimicrob Chemother; 1986 Mar; 17(3):297-302. PubMed ID: 3457785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro susceptibility to antibiotics and sulfonamides of atypical mycobacteria isolated in South America.
    de Kantor IN; Barrera L; di Lonardo M
    Zentralbl Bakteriol Mikrobiol Hyg A; 1985 Oct; 260(2):247-53. PubMed ID: 4082825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug susceptibility of rapid and slow growing non-tuberculous mycobacteria isolated from symptomatics for pulmonary tuberculosis, Central India.
    Goswami B; Narang P; Mishra PS; Narang R; Narang U; Mendiratta DK
    Indian J Med Microbiol; 2016; 34(4):442-447. PubMed ID: 27934821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiometric studies on the use of selective inhibitors in the identification of Mycobacterium spp.
    Collins T; Levett PN
    J Med Microbiol; 1989 Nov; 30(3):175-81. PubMed ID: 2511320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro activity of ciprofloxacin against clinical isolates of mycobacteria resistant to antimycobacterial drugs.
    Marinis E; Legakis NJ
    J Antimicrob Chemother; 1985 Oct; 16(4):527-30. PubMed ID: 2933382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First Korean Case of Mycobacterium arupense tenosynovitis.
    Lee SJ; Hong SK; Park SS; Kim EC
    Ann Lab Med; 2014 Jul; 34(4):321-4. PubMed ID: 24982839
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.